Koehorst S G, Jacobs H M, Thijssen J H, Blankenstein M A
Department of Endocrinology, Academic Hospital Utrecht, The Netherlands.
Br J Cancer. 1993 Aug;68(2):290-4. doi: 10.1038/bjc.1993.330.
When a ligand binding or enzyme immunoassay is used, meningiomas are found to be rich in progestin receptors (PR) whereas oestrogen receptors (ER) are virtually undetectable. A protein that can bind to an oestrogen responsive element (ERE) was detected in meningiomas, by using the band-shift assay. The binding of ER to the ERE is inhibited by the anti-ER monoclonal antibody ER-P31, which is directed to the A/B domain of the ER, indicating that the binding protein is an ER-like protein.